A Single-Arm Registrational Phase III Study of Olverembatinib in the Treatment of Patients with SDH-Deficient Gastrointestinal Stromal Tumor [POLARIS-3] (NCT06640361)
POLARIS-3
This trial is No longer recruiting
Registration number NCT06640361
Program & service
This trial is being run with the Cancer service, and as part of the Medical Oncology program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor John Zalcberg
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR